Sana Biotechnology

Forecast & Rating10 analysts currently cover Sana Biotechnology, with about 80.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $8.43, about 228.0% upside from the current price of $2.57. Price targets range from $6.00 to $12.00 — a wide spread, showing clear disagreement over just how much Sana Biotechnology can rise. Historically, about 31.4% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Sana Biotechnology closely still see room for the stock to rise. Data as of Aug 21, 2026; for reference only and not investment advice.